- Research works
- 1 fractional, all time
- Citations
- 9 10.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 70% world 28%
Not ranked overall: Suzhou Hongyuan Biotech Inc. (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Suzhou Hongyuan Biotech Inc. (China) publish most on?
By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies and Urinary Tract Infections Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bladder and Urothelial Cancer Treatments Surgery 0 works
- 2 Urinary and Genital Oncology Studies Surgery 0 works
- 3 Urinary Tract Infections Management Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Suzhou Hongyuan Biotech Inc. (China)'s research output changed?
Other research institutions in Suzhou
- Suzhou City University
- The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
- Jiangnan Social University
- Changshu No. 2 People's Hospital
- Suzhou Institute of North China Electric Power University
- Suzhou Yongding Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.